Department of Psychology, Medical School Hamburg, Hamburg, Germany.
Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
J Psychosom Res. 2024 Apr;179:111616. doi: 10.1016/j.jpsychores.2024.111616. Epub 2024 Feb 20.
Treatment expectations alter the probability of experiencing unpleasant side effects from an intervention, including vaccinations. To date, expectations have mostly been assessed explicitly bearing the risk of bias. This study aims to compare implicit expectations of side effects from COVID-19 and flu vaccinations and to examine their relationships with vaccine attitudes and intentions.
N = 248 participants took part in a cross-sectional online survey assessing explicit and implicit expectations, as well as vaccine-related attitudes and personal characteristics. A Single Category Implicit Association Test (SC-IAT) was developed to assess implicit side effect expectations. Explicit side effect expectations were measured with the Treatment Expectation Questionnaire (TEX-Q).
Whereas explicit and implicit expectations regarding COVID-19 vaccine were significantly correlated (r = -0.325, p < .001), those correlations could not be found regarding flu vaccine (r = -0.072, p = .32). Explicit measures (COVID-19: β = -0.576, p < .001; flu: β = -0.301, p < .001) predicted the intention to receive further vaccinations more than implicit measures (COVID-19: β = -0.005, p = .93; flu: β = 0.004, p = .96). Explicit measures (COVID-19: OR = 0.360, p < .001; flu: OR = 0.819, p = .03) predicted vaccination status, while implicit measures did not (COVID- 19: OR = 2.643, p = .35; flu: OR = 0.829, p = .61).
Expectations to experience side effects from vaccinations can be measured implicitly, in addition to explicit measures. Further investigation needs to determine the relative contribution and additive value of using implicit measures to assess treatment expectations.
治疗预期会改变干预措施(包括疫苗接种)产生不良副作用的可能性。迄今为止,预期主要通过具有偏见风险的明确评估来评估。本研究旨在比较 COVID-19 和流感疫苗的隐性副作用预期,并研究其与疫苗态度和意图的关系。
N=248 名参与者参加了一项横断面在线调查,评估了明确和隐性预期、疫苗相关态度和个人特征。开发了一个单类别内隐联想测验(SC-IAT)来评估隐性副作用预期。显性副作用预期用治疗预期问卷(TEX-Q)进行测量。
尽管 COVID-19 疫苗的显性和隐性预期显著相关(r=-0.325,p<.001),但不能发现流感疫苗的相关性(r=-0.072,p=.32)。显性测量(COVID-19:β=-0.576,p<.001;流感:β=-0.301,p<.001)比隐性测量(COVID-19:β=-0.005,p=.93;流感:β=0.004,p=.96)更能预测进一步接种疫苗的意愿。显性测量(COVID-19:OR=0.360,p<.001;流感:OR=0.819,p=.03)预测了疫苗接种状况,而隐性测量则没有(COVID-19:OR=2.643,p=.35;流感:OR=0.829,p=.61)。
除了显性测量外,还可以通过隐性测量来衡量对疫苗接种产生副作用的预期。需要进一步研究来确定使用隐性测量来评估治疗预期的相对贡献和附加价值。